{"entity":{"type":"insider","cik":"0001542517","url":"/insider/0001542517","json_url":"/insider/0001542517.json","name":"Grossman Adam S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":86,"n_filings":46,"first":"2013-10-23","last":"2026-03-17","span_basis":"filed_date"},"name_variants":[{"name":"Grossman Adam S","source":"filing","n_filings":46,"first_seen":"2013-10-23","last_seen":"2026-03-17"}],"transactions":[{"id":5835905,"accession":"0001140361-26-009899","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-26-009899","line_url":"/filing/0001140361-26-009899","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":15.16,"price_display":"15.16","price_state":"stated","total_value":318360.0,"total_display":"318,360.00","total_whole":"318,360","shares_owned_after":2118777.0,"shares_owned_after_display":"2,118,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-17","scope":"insider","n_lines":2},{"id":5918577,"accession":"0001140361-26-005888","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-26-005888","line_url":"/filing/0001140361-26-005888","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":16.08,"price_display":"16.08","price_state":"stated","total_value":337680.0,"total_display":"337,680.00","total_whole":"337,680","shares_owned_after":2290379.0,"shares_owned_after_display":"2,290,379","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-17","scope":"insider","n_lines":2},{"id":4170667,"accession":"0001140361-25-045737","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-045737","line_url":"/filing/0001140361-25-045737","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":19.79,"price_display":"19.79","price_state":"stated","total_value":415590.0,"total_display":"415,590.00","total_whole":"415,590","shares_owned_after":2013850.0,"shares_owned_after_display":"2,013,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-16","scope":"insider","n_lines":2},{"id":4455722,"accession":"0001140361-25-042997","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-042997","line_url":"/filing/0001140361-25-042997","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":336000.0,"total_display":"336,000.00","total_whole":"336,000","shares_owned_after":2019850.0,"shares_owned_after_display":"2,019,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-19","filed_date":"2025-11-21","scope":"insider","n_lines":2},{"id":4622158,"accession":"0001140361-25-039331","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-039331","line_url":"/filing/0001140361-25-039331","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":336000.0,"total_display":"336,000.00","total_whole":"336,000","shares_owned_after":2025850.0,"shares_owned_after_display":"2,025,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-24","filed_date":"2025-10-24","scope":"insider","n_lines":2},{"id":4065672,"accession":"0001140361-25-035159","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-035159","line_url":"/filing/0001140361-25-035159","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":16.13,"price_display":"16.13","price_state":"stated","total_value":338730.0,"total_display":"338,730.00","total_whole":"338,730","shares_owned_after":2031850.0,"shares_owned_after_display":"2,031,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-15","filed_date":"2025-09-16","scope":"insider","n_lines":2},{"id":4530466,"accession":"0001140361-25-031601","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-031601","line_url":"/filing/0001140361-25-031601","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":16.88,"price_display":"16.88","price_state":"stated","total_value":354480.0,"total_display":"354,480.00","total_whole":"354,480","shares_owned_after":2037850.0,"shares_owned_after_display":"2,037,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-15","scope":"insider","n_lines":2},{"id":5024420,"accession":"0001140361-25-026099","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-026099","line_url":"/filing/0001140361-25-026099","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":18.66,"price_display":"18.66","price_state":"stated","total_value":391860.0,"total_display":"391,860.00","total_whole":"391,860","shares_owned_after":2043850.0,"shares_owned_after_display":"2,043,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-15","filed_date":"2025-07-16","scope":"insider","n_lines":2},{"id":5182088,"accession":"0001140361-25-023017","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-023017","line_url":"/filing/0001140361-25-023017","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":20.81,"price_display":"20.81","price_state":"stated","total_value":437010.0,"total_display":"437,010.00","total_whole":"437,010","shares_owned_after":2049850.0,"shares_owned_after_display":"2,049,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-16","filed_date":"2025-06-18","scope":"insider","n_lines":2},{"id":4844443,"accession":"0001140361-25-019589","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-019589","line_url":"/filing/0001140361-25-019589","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":19.45,"price_display":"19.45","price_state":"stated","total_value":408450.0,"total_display":"408,450.00","total_whole":"408,450","shares_owned_after":2055850.0,"shares_owned_after_display":"2,055,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-15","filed_date":"2025-05-16","scope":"insider","n_lines":2},{"id":4425082,"accession":"0001140361-25-014267","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-014267","line_url":"/filing/0001140361-25-014267","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":21.46,"price_display":"21.46","price_state":"stated","total_value":450660.0,"total_display":"450,660.00","total_whole":"450,660","shares_owned_after":2061850.0,"shares_owned_after_display":"2,061,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-15","filed_date":"2025-04-16","scope":"insider","n_lines":2},{"id":4425066,"accession":"0001140361-25-009928","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-009928","line_url":"/filing/0001140361-25-009928","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":18.92,"price_display":"18.92","price_state":"stated","total_value":397320.0,"total_display":"397,320.00","total_whole":"397,320","shares_owned_after":2067850.0,"shares_owned_after_display":"2,067,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-21","scope":"insider","n_lines":2},{"id":2937363,"accession":"0001140361-24-047701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-24-047701","line_url":"/filing/0001140361-24-047701#line-1","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48967.0,"shares_display":"48,967","price_per_share":21.1,"price_display":"21.10","price_state":"stated","total_value":1033203.7,"total_display":"1,033,203.70","total_whole":"1,033,204","shares_owned_after":1989007.0,"shares_owned_after_display":"1,989,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-22","filed_date":"2024-11-22","scope":"insider"},{"id":2242610,"accession":"0001140361-24-038772","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001140361-24-038772","line_url":"/filing/0001140361-24-038772#line-9","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":389356.0,"shares_display":"389,356","price_per_share":17.2924,"price_display":"17.29","price_state":"stated","total_value":6732899.6944,"total_display":"6,732,899.69","total_whole":"6,732,900","shares_owned_after":2059726.0,"shares_owned_after_display":"2,059,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-27","filed_date":"2024-08-27","scope":"insider"},{"id":2242598,"accession":"0001140361-24-038772","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-24-038772","line_url":"/filing/0001140361-24-038772#line-6","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":236889.0,"shares_display":"236,889","price_per_share":17.6922,"price_display":"17.69","price_state":"stated","total_value":4191087.5658,"total_display":"4,191,087.57","total_whole":"4,191,088","shares_owned_after":2059726.0,"shares_owned_after_display":"2,059,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-27","scope":"insider"},{"id":2937104,"accession":"0001140361-24-030232","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-24-030232","line_url":"/filing/0001140361-24-030232#line-3","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President,CEO, and Interim CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President,CEO, and Interim CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":10.7198,"price_display":"10.72","price_state":"stated","total_value":1071980.0,"total_display":"1,071,980.00","total_whole":"1,071,980","shares_owned_after":2081475.0,"shares_owned_after_display":"2,081,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-14","filed_date":"2024-06-14","scope":"insider"},{"id":8389667,"accession":"0001140361-23-040583","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-040583","line_url":"/filing/0001140361-23-040583#line-1","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":4.1534,"price_display":"4.15","price_state":"stated","total_value":1038350.0,"total_display":"1,038,350.00","total_whole":"1,038,350","shares_owned_after":2273085.0,"shares_owned_after_display":"2,273,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-18","filed_date":"2023-08-18","scope":"insider"},{"id":8731277,"accession":"0001140361-23-040322","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001140361-23-040322","line_url":"/filing/0001140361-23-040322#line-9","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3.0,"shares_display":"3","price_per_share":4.385,"price_display":"4.38","price_state":"stated","total_value":13.155,"total_display":"13.16","total_whole":"13","shares_owned_after":2523085.0,"shares_owned_after_display":"2,523,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-17","scope":"insider"},{"id":8731274,"accession":"0001140361-23-040322","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001140361-23-040322","line_url":"/filing/0001140361-23-040322#line-8","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":510469.0,"shares_display":"510,469","price_per_share":4.5428,"price_display":"4.54","price_state":"stated","total_value":2318958.5732,"total_display":"2,318,958.57","total_whole":"2,318,959","shares_owned_after":4113075.0,"shares_owned_after_display":"4,113,075","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-15","filed_date":"2023-08-17","scope":"insider"},{"id":6915826,"accession":"0001140361-22-045111","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-045111","line_url":"/filing/0001140361-22-045111","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29965.0,"shares_display":"29,965","price_per_share":2.86,"price_display":"2.86","price_state":"stated","total_value":85699.9,"total_display":"85,699.90","total_whole":"85,700","shares_owned_after":2203708.0,"shares_owned_after_display":"2,203,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-09","filed_date":"2022-12-09","scope":"insider","n_lines":2},{"id":4412842,"accession":"0001140361-21-035379","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-21-035379","line_url":"/filing/0001140361-21-035379","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":350000.0,"total_display":"350,000.00","total_whole":"350,000","shares_owned_after":1128444.0,"shares_owned_after_display":"1,128,444","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-25","filed_date":"2021-10-26","scope":"insider","n_lines":2},{"id":3252857,"accession":"0001193805-20-001128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-20-001128","line_url":"/filing/0001193805-20-001128#line-1","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":2.2399,"price_display":"2.24","price_state":"stated","total_value":8959.6,"total_display":"8,959.60","total_whole":"8,960","shares_owned_after":176098.0,"shares_owned_after_display":"176,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-10","scope":"insider"},{"id":2355980,"accession":"0001193805-20-001005","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-20-001005","line_url":"/filing/0001193805-20-001005#line-4","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":2970.0,"total_display":"2,970.00","total_whole":"2,970","shares_owned_after":172098.0,"shares_owned_after_display":"172,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-11","filed_date":"2020-08-12","scope":"insider"},{"id":2355977,"accession":"0001193805-20-001005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-20-001005","line_url":"/filing/0001193805-20-001005","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.05798,"price_display":"3.06","price_state":"stated","total_value":15289.9,"total_display":"15,289.90","total_whole":"15,290","shares_owned_after":169098.0,"shares_owned_after_display":"169,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-10","filed_date":"2020-08-12","scope":"insider","n_lines":3},{"id":2816934,"accession":"0001193805-20-000127","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-20-000127","line_url":"/filing/0001193805-20-000127","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":85714.0,"shares_display":"85,714","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":299999.0,"total_display":"299,999.00","total_whole":"299,999","shares_owned_after":878444.0,"shares_owned_after_display":"878,444","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-11","scope":"insider","n_lines":2},{"id":8097690,"accession":"0001193805-19-000520","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-19-000520","line_url":"/filing/0001193805-19-000520","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":120000.0,"total_display":"120,000.00","total_whole":"120,000","shares_owned_after":821301.0,"shares_owned_after_display":"821,301","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-17","filed_date":"2019-05-21","scope":"insider","n_lines":2},{"id":6579673,"accession":"0001193805-18-000820","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-18-000820","line_url":"/filing/0001193805-18-000820","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":73222.0,"shares_display":"73,222","price_per_share":4.78,"price_display":"4.78","price_state":"stated","total_value":350001.16,"total_display":"350,001.16","total_whole":"350,001","shares_owned_after":796301.0,"shares_owned_after_display":"796,301","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-11","scope":"insider","n_lines":2},{"id":4705539,"accession":"0001193805-17-003451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-17-003451","line_url":"/filing/0001193805-17-003451#line-1","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":485000.0,"shares_display":"485,000","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":1042750.0,"total_display":"1,042,750.00","total_whole":"1,042,750","shares_owned_after":744000.0,"shares_owned_after_display":"744,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-09","filed_date":"2017-11-13","scope":"insider"},{"id":2583168,"accession":"0001193805-16-003191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-16-003191","line_url":"/filing/0001193805-16-003191#line-1","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":1300000.0,"total_display":"1,300,000.00","total_whole":"1,300,000","shares_owned_after":843668.0,"shares_owned_after_display":"843,668","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-03","filed_date":"2016-05-05","scope":"insider"},{"id":8284829,"accession":"0001193805-15-002118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-15-002118","line_url":"/filing/0001193805-15-002118#line-1","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6400.0,"shares_display":"6,400","price_per_share":8.4725,"price_display":"8.47","price_state":"stated","total_value":54224.0,"total_display":"54,224.00","total_whole":"54,224","shares_owned_after":643668.0,"shares_owned_after_display":"643,668","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-18","filed_date":"2015-12-22","scope":"insider"},{"id":8119328,"accession":"0001193805-15-002011","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-15-002011","line_url":"/filing/0001193805-15-002011#line-3","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001542517","owner_name":"Grossman Adam S","owner_display_name":"Grossman Adam S","owner_url":"/insider/0001542517","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":8.9901,"price_display":"8.99","price_state":"stated","total_value":2697.03,"total_display":"2,697.03","total_whole":"2,697","shares_owned_after":637268.0,"shares_owned_after_display":"637,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-08","filed_date":"2015-12-09","scope":"insider"}],"collapsed":true,"next_cursor":"2015-12-08|8119328","ledger_fault":false,"count":{"value":86,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":55,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":86},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001368514","name":"ADMA BIOLOGICS, INC.","url":"/issuer/0001368514","role":"Director, Officer (President and CEO)","n_filings":46,"first_seen":"2013-10-23","last_seen":"2026-03-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001542517","retrieved_at":"2026-08-27T20:24:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}